This Article Full Text Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Iacoviello, L. Articles by Donati, M. B. Search for Related Content PubMed PubMed Citation Articles by Iacoviello, L. Articles by Donati, M. B.

(Arteriosclerosis, Thrombosis, and Vascular Biology. 1995;15:2037-2046.)
© 1995 American Heart Association, Inc.

Articles

Human Endothelial Cell Damage by Neutrophil-Derived Cathepsin G

Role of Cytoskeleton Rearrangement and Matrix-Bound Plasminogen Activator Inhibitor-1

Licia Iacoviello; Valeri Kolpakov; Lorena Salvatore; Concetta Amore; Giuseppe Pintucci; Giovanni de Gaetano; Maria Benedetta Donati

From the "Angela Valenti" Laboratory of Thrombosis Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri, Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy.

Correspondence to Dr Licia Iacoviello, "Angela Valenti" Laboratory of Thrombosis Pharmacology, Consorzio Mario Negri Sud via Nazionale, 66030 Santa Maria Imbaro (Chieti), Italy.

Abstract Cathepsin G, a major protease released by activated neutrophils, induces functional and morphological damage to human endothelial cells. We studied the mechanisms involved and ways to reverse this damage. Cathepsin G induced a concentration- and time-dependent injury to human umbilical vein endothelial cell (HUVEC) morphology simultaneous with cytoskeleton rearrangement. Preincubation of the endothelial monolayer with phallacidin completely prevented damage to cell morphology by cathepsin G, whereas preincubation with cytochalasin B potentiated its activity. Damage to cell shape and F-actin cytoskeleton were prevented by eglin C, an inhibitor of the active site of cathepsin G. Furthermore, cathepsin G increased transcellular permeability to albumin and induced a time-dependent detachment of PAI-1 from the extracellular matrix of a cell-free system. The inhibition of matrix-bound PAI-1 activity by specific antibodies induced changes in HUVEC monolayers similar to those observed after cathepsin G. However, although stabilization of F-actin microfilaments by phallacidin prevented changes in cell shape, it did not prevent the ability of cathepsin G to increase cell permeability and release matrix PAI-1. The damage of cathepsin G to cell morphology and cytoskeleton arrangement was reversed within 12 hours if the deendothelialization area was <50% to 55% and the subendothelial matrix was still able to bind the newly synthesized PAI-1. Thrombin, whose role in the thrombotic process is well known, also induced changes in cell morphology and cytoskeleton arrangement of HUVEC. Cathepsin G reaches the subendothelial matrix through an increase in cell permeability and injures endothelial cell morphology by detaching matrix-bound PAI-1. These events expose a highly thrombogenic surface to which platelets can adhere, become activated, attract further neutrophils, and trigger thrombus formation.

Key Words: cathepsin G • neutrophils • PAI-1 • cytoskeleton • endothelial damage

This article has been cited by other articles:

				P. Michaluk, L. Mikasova, L. Groc, R. Frischknecht, D. Choquet, and L. Kaczmarek Matrix Metalloproteinase-9 Controls NMDA Receptor Surface Diffusion through Integrin {beta}1 Signaling J. Neurosci., May 6, 2009; 29(18): 6007 - 6012. [Abstract] [Full Text] [PDF]

				S. F. Steinberg The Cardiovascular Actions of Protease-Activated Receptors Mol. Pharmacol., January 1, 2005; 67(1): 2 - 11. [Abstract] [Full Text] [PDF]

				S. Stefansson, M. Yepes, N. Gorlatova, D. E. Day, E. G. Moore, A. Zabaleta, G. A. McMahon, and D. A. Lawrence Mutants of Plasminogen Activator Inhibitor-1 Designed to Inhibit Neutrophil Elastase and Cathepsin G Are More Effective in Vivo than Their Endogenous Inhibitors J. Biol. Chem., July 16, 2004; 279(29): 29981 - 29987. [Abstract] [Full Text] [PDF]

				J.-B. Michel Anoikis in the Cardiovascular System: Known and Unknown Extracellular Mediators Arterioscler Thromb Vasc Biol, December 1, 2003; 23(12): 2146 - 2154. [Abstract] [Full Text] [PDF]

				A. Sabri, S. G. Alcott, H. Elouardighi, E. Pak, C. Derian, P. Andrade-Gordon, K. Kinnally, and S. F. Steinberg Neutrophil Cathepsin G Promotes Detachment-induced Cardiomyocyte Apoptosis via a Protease-activated Receptor-independent Mechanism J. Biol. Chem., June 20, 2003; 278(26): 23944 - 23954. [Abstract] [Full Text] [PDF]

				S.-M. Herrmann, H. Funke-Kaiser, K. Schmidt-Petersen, V. Nicaud, M. Gautier-Bertrand, A. Evans, F. Kee, D. Arveiler, C. Morrison, H.-D. Orzechowski, et al. Characterization of Polymorphic Structure of Cathepsin G Gene: Role in Cardiovascular and Cerebrovascular Diseases Arterioscler Thromb Vasc Biol, September 1, 2001; 21(9): 1538 - 1543. [Abstract] [Full Text] [PDF]